Shujun Xie

1.7k total citations · 1 hit paper
22 papers, 1.2k citations indexed

About

Shujun Xie is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shujun Xie has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Shujun Xie's work include Inflammasome and immune disorders (7 papers), Cell death mechanisms and regulation (2 papers) and Tryptophan and brain disorders (2 papers). Shujun Xie is often cited by papers focused on Inflammasome and immune disorders (7 papers), Cell death mechanisms and regulation (2 papers) and Tryptophan and brain disorders (2 papers). Shujun Xie collaborates with scholars based in China, Singapore and Canada. Shujun Xie's co-authors include Dajing Xia, Di Wang, Chuansheng Guo, Mingzhu Zheng, Zhexu Chi, Jinhua Zhang, Yangyang Liu, Li Zhang, Yuehai Ke and Xue Zhang and has published in prestigious journals such as Immunity, Biomaterials and International Journal of Molecular Sciences.

In The Last Decade

Shujun Xie

21 papers receiving 1.2k citations

Hit Papers

Bile Acids Control Inflam... 2016 2026 2019 2022 2016 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shujun Xie China 13 642 246 228 184 183 22 1.2k
Dajing Xia China 12 627 1.0× 281 1.1× 213 0.9× 189 1.0× 151 0.8× 28 1.2k
Zizhen Gong China 13 557 0.9× 211 0.9× 140 0.6× 169 0.9× 163 0.9× 32 1.0k
Shannon D. McClintock United States 18 375 0.6× 315 1.3× 144 0.6× 155 0.8× 119 0.7× 38 1.2k
Te‐Mao Li Taiwan 24 555 0.9× 125 0.5× 207 0.9× 135 0.7× 78 0.4× 53 1.3k
Sanjeev Noel United States 23 556 0.9× 427 1.7× 126 0.6× 112 0.6× 139 0.8× 48 1.5k
Zhexu Chi China 13 1.1k 1.8× 487 2.0× 218 1.0× 235 1.3× 246 1.3× 17 1.7k
Zhengwu Sun China 22 468 0.7× 232 0.9× 118 0.5× 156 0.8× 312 1.7× 43 1.4k
Yanchun Li China 17 420 0.7× 143 0.6× 134 0.6× 197 1.1× 64 0.3× 56 952
Wenxian Guan China 18 443 0.7× 430 1.7× 207 0.9× 206 1.1× 219 1.2× 50 1.3k

Countries citing papers authored by Shujun Xie

Since Specialization
Citations

This map shows the geographic impact of Shujun Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujun Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujun Xie more than expected).

Fields of papers citing papers by Shujun Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujun Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujun Xie. The network helps show where Shujun Xie may publish in the future.

Co-authorship network of co-authors of Shujun Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Shujun Xie. A scholar is included among the top collaborators of Shujun Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujun Xie. Shujun Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hanwen, Shujun Xie, Yichen Zhou, et al.. (2024). MEK1/2 promote ROS production and deubiquitinate NLRP3 independent of ERK1/2 during NLRP3 inflammasome activation. Biochemical Pharmacology. 230(Pt 1). 116572–116572.
2.
3.
Zhao, Yanyan, Shen Gu, Lingjie Li, et al.. (2023). A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma. Neuro-Oncology. 25(12). 2207–2220. 11 indexed citations
4.
Zhang, Jing, et al.. (2023). Identification of mitophagy-related biomarkers and immune infiltration in major depressive disorder. BMC Genomics. 24(1). 216–216. 12 indexed citations
5.
Xie, Shujun, Lingqiao Wang, Lili Yan, et al.. (2023). Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS/Cl− efflux signaling pathway. Journal of Translational Medicine. 21(1). 452–452. 19 indexed citations
7.
Zhang, Jing, et al.. (2022). Comprehensive analysis of endoplasmic reticulum stress and immune infiltration in major depressive disorder. Frontiers in Psychiatry. 13. 1008124–1008124. 9 indexed citations
8.
Zhang, Jingjing, Qiong Wu, Lucheng Zhu, et al.. (2021). SERPINE2/PN-1 regulates the DNA damage response and radioresistance by activating ATM in lung cancer. Cancer Letters. 524. 268–283. 59 indexed citations
9.
Huang, Bo, Yufeng Qian, Shujun Xie, et al.. (2020). Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway. Cellular and Molecular Immunology. 18(5). 1278–1289. 49 indexed citations
10.
11.
Huang, Fang, Zhifeng Chen, Hanwen Chen, et al.. (2018). Cypermethrin Promotes Lung Cancer Metastasis via Modulation of Macrophage Polarization by Targeting MicroRNA-155/Bcl6. Toxicological Sciences. 163(2). 454–465. 31 indexed citations
12.
He, Bin, et al.. (2018). Assessment of radiation exposure in balloon kyphoplasty using a new navigation system. Minimally Invasive Therapy & Allied Technologies. 27(6). 347–354. 4 indexed citations
13.
Chen, Hanwen, Shujun Xie, Bo Huang, et al.. (2018). Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROS-independent NLRP3 ubiquitination. Toxicology and Applied Pharmacology. 365. 19–29. 56 indexed citations
14.
Zhang, Shirong, Jian Liu, Fang Liu, et al.. (2017). Mesenchymal phenotype of circulating tumor cells is associated with distant metastasis in breast cancer patients. Cancer Management and Research. Volume 9. 691–700. 33 indexed citations
15.
Xu, Jian, Yihua Wu, Guang Lu, et al.. (2017). Importance of ROS-mediated autophagy in determining apoptotic cell death induced by physapubescin B. Redox Biology. 12. 198–207. 54 indexed citations
16.
Guo, Chuansheng, Shujun Xie, Zhexu Chi, et al.. (2016). Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. Immunity. 45(4). 802–816. 635 indexed citations breakdown →
17.
Huang, Fang, Qiaoyun Liu, Shujun Xie, et al.. (2016). Cypermethrin Induces Macrophages Death through Cell Cycle Arrest and Oxidative Stress-Mediated JNK/ERK Signaling Regulated Apoptosis. International Journal of Molecular Sciences. 17(6). 885–885. 67 indexed citations
18.
Xie, Shujun, Jing Feng, Yingliang Wu, et al.. (2012). Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus. Peptides. 36(1). 94–99. 12 indexed citations
19.
Xie, Shujun, Qin Zhu, Bin Wang, et al.. (2010). Incorporation of tripolyphosphate nanoparticles into fibrous poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 31(19). 5100–5109. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026